BCL2 and acute lymphoblastic leukemia: Using the anti-Bcl-2 drug obatoclax in GC-resistant T-ALL cell lines showed increased autophagy mediated by dissociation of Beclin-1 from Bcl-2 family member Mcl-1 and reduced mTORC1 activity (108).